Fennec Pharmaceuticals (NASDAQ: FENC) reported Q3 EPS of ($0.21), $0.11 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $6.97 million versus the consensus estimate of $8.82 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.